Biological and clinical implications of interleukin-7 and lymphopolesis

Cytokines, Cellular and Molecular Therapy

Volumn 5, Issue 1, 1999, Pages 25-39

  Appasamy, Pierette M ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

T cell; Anti apoptosis; Cytokines; Interleukin 7; Lymphopoiesis; Stromal cell

Indexed keywords

CYTOKINE; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; SIGNAL PEPTIDE;

ALPHA CHAIN; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; B LYMPHOCYTE; BINDING AFFINITY; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MATURATION; DERMATOLOGY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENE THERAPY; HUMAN; IMMUNOTHERAPY; INTESTINE MUCOSA; LYMPHOPOIESIS; MACROPHAGE ACTIVATION; METASTASIS; MOLECULAR BIOLOGY; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; STROMA CELL; T LYMPHOCYTE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; B-LYMPHOCYTES; HEMATOPOIESIS; HUMANS; INTERLEUKIN-7; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0032911491     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (202)

1. Mackensen A, Lindemann A, Mertelsmann R, Immunostimulatory cytokines in somatic cells and gene therapy of cancer. Cytokine Growth Factor Rev (1997) 8: 119-28.
2. Komschlies KL, Grzegorzewski KJ, Wiltrout RH, Diverse immunological and hematological effects of interleukin 7: implications for clinical application. J Leukoc Biol (1995) 58: 623-33.
3. Park LS, Morrissey PJ, Davison B, Grabstein K, The role of IL-7 and its receptor in B-cell ontogeny. In: Mechanisms of Lymphocyte Activation and Immune Regulation IV: Cellular Communications (ed S Gupta, TA Waldmann) 125-9. Plenum Press, New York, 1992.
4. Rosenberg N, Kincade PW, B-lineage differentiation in normal and transformed cells and the microenvironment that supports it. Curr Opin Immunol (1994) 6: 203-11.
5. Takatsu K, Cytokines involved in B-cell differentiation and their sites of action. Proc Soc Exp Biol Med (1997) 215: 121-33.
6. Namen AE, Schmierer AE, March CJ et al, B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med (1988) 167: 988-1002.
7. Appasamy PM, Interleukin-7 and lymphopoiesis. In: Cytokines in Health and Disease (ed DG Remick, JS Friedland) 101-20. Marcel Dekker, New York, 1997.
8. Namen AE, Lupton S, Hjerrild K et al, Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature (1988) 333: 571-3.
9. Goodwin RG, Lupton S, Schmierer A et al, Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA (1989) 86: 302-6.
10. Conlon PJ, Morrissey PJ, Nordan RP et al, Murine thymocytes proliferate in direct response to interleukin-7. Blood (1989) 74: 1368-73.
11. Watson JD, Morrissey PJ, Namen AE et al, Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol (1989) 143: 1215-22.
12. Watanabe Y, Sudo T, Minato N et al, Interleukin 7 preferentially supports the growth of gamma delta T cell receptor-bearing T cells from fetal thymocytes in vitro. Int Immunol (1991) 3: 1067-75.
13. Morrissey PJ, Conlon P, Charrier K et al, Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. J Immunol (1991) 147: 561-8.
14. Komschlies KL, Gregorio TA, Gruys ME et al, Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases. J Immunol (1994) 152: 5776-84.
15. Samaridis J, Casorati G, Traunecker A et al, Development of lymphocytes in interleukin 7-transgenic mice. Eur J Immunol (1991) 21: 453-60.
16. Rich BE, Campos Torres J, Tepper RI et al, Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J Exp Med (1993) 177: 305-16.
17. Uehira M, Matsuda H, Hikita I et al, The development of dermatitis infiltrated by gamma delta T cells in IL-7 transgenic mice. Int Immunol (1993) 5: 1619-27.
18. Fisher AG, Burdet C, LeMeur M et al, Lymphoproliferative disorders in an IL-7 transgenic mouse line. Leukemia (1993) 7(Suppl 2): S66-8.
19. Morrissey PJ, Conlon P, Braddy S et al, Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation. J Immunol (1991) 146: 1547-52.
20. Peschon JJ, Morrissey PJ, Grabstein KH et al, Early lymphocyte expansion is severely impaired in interleukin-7 receptor deficient mice. J Exp Med (1994) 180: 1955-60.
21. von Freeden-Jeffry U, Vieira P, Lucian LA et al, Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med (1995) 181: 1519-26.
22. Sutherland GR, Baker E, Fernandez KE et al, The gene for human interleukin 7 (IL7) is at 8q12-13. Hum Genet (1989) 82: 371-2.
23. Corey SJ, Shapiro DN, Localization of the human gene for Src-related protein tyrosine kinase LYN to chromosome Sq11-12: a lymphoid signaling cluster? Leukemia (1994) 8: 1914-17.
24. Seckinger P, Fougereau M, Activation of src family kinases in human pre-B cells by IL-7. J Immunol (1994) 153: 97-109.
25. Kondo M, Takeshita T, Higuchi M et al, Functional participation of the IL-2 receptor γ chain in IL-7 receptor complexes. Science (1994) 263: 1453-4.
26. Kondo M, Takeshita T, Ishii N et al, Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science (1993) 262: 1874-7.
27. Noguchi M, Nakamura Y, Russell SM et al, Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science (1993) 262: 1877-80.
28. Russell SM, Keegan AD, Harada N et al, Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science (1993) 262: 1880-3.
29. Russell SM, Johnston JA, Noguchi M et al, Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science (1994) 266: 1042-5.
30. Giri JG, Ahdieh M, Eisenman J et al, Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J (1994) 13: 2822-30.
31. Park LS, Friend DJ, Schmierer AE et al, Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. J Exp Med (1990) 171: 1073-89.
32. Lai SY, Molden J, Goldsmith MA, Shared γc subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency. J Clin Invest (1997) 99: 169-77.
33. Goodwin RG, Friend D, Ziegler SF et al, Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell (1990) 60: 941-51.
34. Lynch M, Baker E, Park LS et al, The interleukin-7 receptor gene is at 5p13. Hum Genet (1992) 89: 566-8.
35. Gearing DP, Druck T, Huebner K et al, The leukemia inhibitory factor receptor (LIFR) gene is located within a cluster of cytokine receptor loci on mouse chromosome 15 and human chromosome 5p12-p13. Genomics (1993) 18: 148-50.
36. Aggarwal BB, Pocsik E, Cytokines: from clone to clinic. Arch Biochem Biophys (1992) 292: 335-59.
37. Ray RJ, Furlonger C, Williams DE, Paige CJ, Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol (1996) 26: 10-16.
38. Taniguchi T, Minami Y, The IL-2/IL-2 receptor system: a current overview. Cell (1993) 73: 5-8.
39. Dibirdik I, Langlie MC, Ledbetter JA et al, Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells. Blood (1991) 78: 564-70.
40. Uckun FM, Dibirdik I, Smith R et al, Interleukin 7 receptor ligation stimulates tyrosine phosphorylation, inositol phospholipid turnover, and clonal proliferation of human B-cell precursors. Proc Natl Acad Sci USA (1991) 88: 3589-93.
41. Uckun FM, Tuel Ahlgren L, Obuz V et al, Interleukin 7 receptor engagement stimulates tyrosine phosphorylation, inositol phospholipid turnover, proliferation, and selective differentiation to the CD4 lineage by human fetal thymocytes. Proc Natl Acad Sci USA (1991) 88: 6323-7.
42. Roifman CM, Wang GX, Freedman M, Pan ZQ, IL-7 receptor mediates tyrosine phosphorylation but does not activate the phosphatidylinositol-phospholipase C-gamma 1 pathway. J Immunol (1992) 148: 1136-42.
43. Venkitaraman AR, Cowling RJ, Interleukin 7 receptor functions by recruiting the tyrosine kinase p59fyn through a segment of its cytoplasmic tail. Proc Natl Acad Sci USA (1992) 89: 12083-7.
44. Seckinger P, Fougereau M, Activation of src family kinases in human pre-B cells by IL-7. J Immunol (1994) 153: 97-109.
45. Dadi HK, Ke S, Roifman CM, Interleukin 7 receptor mediates the activation of phosphatidylinositol-3 kinase in human B-cell precursors. Biochem Biophys Res Commun (1993) 192: 459-64.
46. Dadi HK, Roifman CM, Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor on human thymocytes. J Clin Invest (1993) 92: 1559-63.
47. Crawley JB, Rawlinson L, Lali FV et al, T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation. J Biol Chem (1997) 272: 15023-7.
48. Venkitaraman AR, Cowling RJ, Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the alpha chain of the interleukin-7 receptor. Eur J Immunol (1994) 24: 2168-74.
49. Zeng YX, Takahashi H, Shibata M, Hirokawa K, JAK3 Janus kinase is involved in interleukin 7 signal pathway. FEBS Lett (1994) 353: 289-93.
50. Musso T, Johnston JA, Linnekin D et al, Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med (1995) 181: 1425-31.
51. Darnell JE Jr, STATs and gene regulation. Science (1997) 277: 1630-5.
52. Darnell JE Jr, Kerr IM, Stark GR, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (1994) 264: 1415-20.
53. Lin J-X, Migone T-S, Tsang M et al, The role of shared receptor motifs and common stat proteins in the generation of cytokine pleitropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity (1995) 2: 331-9.
54. Corcoran AE, Smart FM, Cowling RJ et al, The interleukin-7 receptor a chain transmits distinct signals for proliferation and differentiation daring B lymphopoiesis. EMBO J (1996) 15: 1924-32.
55. Sharfe N, Roifman CM, Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7. J Immunol (1997) 159: 1107-14.
56. Perumal NB, Kenniston TW Jr, Tweardy DJ et al, TCR-γ genes are rearranged but not transcribed in IL-7Rα deficient mice. J Immunol (1997) 158: 5744-50.
57. Foxwell BM, Taylor Fishwick DA, Simon JL et al, Activation induced changes in expression and structure of the IL-7 receptor on human T cells. Int Immunol (1992) 4: 277-82.
58. Page TH, Lali FV, Groome N, Foxwell BM, Association of the common gamma-chain with the human IL-7 receptor is modulated by T cell activation. J Immunol (1997) 158: 5727-35.
59. Taniguchi T, Cytokine signaling through nonreceptor protein tyrosine kinases. Science (1995) 268: 251-5.
60. Matsue H, Bergstresser PR, Takashima A, Reciprocal cytokine-mediated cellular interactions in mouse epidermis: promotion of gamma delta T-cell growth by IL-7 and TNF alpha and inhibition of keratinocyte growth by gamma IFN. J Invest Dermatol (1993) 101: 543-8.
61. Matsue H, Bergstresser PR, Takashima A, Keratinocyte-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mice. J Immunol (1993) 151: 6012-19.
62. Heufler C, Topar G, Grasseger A, Stanzl U et al, Interleukin 7 is produced by murine and human keratinocytes. J Exp Med (1993) 178: 1109-14.
63. Araujo DM, Cotman CW, Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res (1993) 600: 49-55.
64. Mehler MF, Rozental R, Dougherty M et al, Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature (1993) 362: 62-5.
65. Updyke LW, Cocke KS, Wierda D, Age-related changes in production of interleukin-7 (IL-7) by murine long-term bone marrow cultures (LTBMC). Mech Ageing Dev (1993) 69: 109-17.
66. Trumper L, Jung W, Dahl G et al, Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein-levels are elevated in the serum of patients with Hodgkin's disease. Ann Oncol (1994) 5: 93-6.
67. DeBenedetti F, Massa M, Pignatti P et al, Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. J Rheumatol (1995) 22: 1581-5.
68. Bonifati C, Trento E, Cordiali-Fei P et al, Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis. Clin Immunol Immunopathol (1997) 83: 41-4.
69. Watanabe M, Watanabe N, Iwao Y et al, The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7. J Clin Immunol (1997) 17: 282-92.
70. Lupton SD, Gimpel S, Jerzy R et al, Characterization of the human and murine IL-7 genes. J Immunol (1990) 144: 3592-601.
71. Arrizumi K, Meng Y, Bergstresser PR, Takashima A, IFN-γ-dependent IL-7 gene regulation in keratinocytes. J Immunol (1995) 154: 6031-9.
72. Tang J, Nuccie BL, Ritterman I et al, TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. J Immunol (1997) 159: 117-25.
73. Ryan DH, Nuccie BL, Ritterman I et al, Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity. Blood (1997) 89: 929-40.
74. Pleiman CM, Gimpel SD, Park LS et al, Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon-inducible promoter. Mol Cell Biol (1991) 11: 3052-9.
75. Yamada G, Ogawa M, Akagi K et al, Specific depletion of the B-cell population induced by aberrant expression of human Interferon regulatory factor 1 gene in transgenic mice. Proc Natl Acad Sci USA (1991) 18: 532-6.
76. Lee G, Namen AE, Gillis S et al, Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta. J Immunol (1989) 142: 3875-83.
77. Sudo T, Ito M, Ogawa Y et al, Interleukin 7 production and function in stromal cell-dependent B cell development. J Exp Med (1989) 170: 333-8.
78. Cumano A, Dorshkind K, Gillis S, Paige CJ, The influence of S17 stromal cells and interleukin 7 on B cell development. Eur J Immunol (1990) 20: 2183-9.
79. Hayashi S, Kunisada T, Ogawa M et al, Stepwise progression of B lineage differentiation supported by interleukin 7 and other stromal cell molecules. J Exp Med (1990) 171: 1683-95.
80. Gunji Y, Sudo T, Suda J et al, Support of early B-cell differentiation in mouse fetal liver by stromal cells and interleukin-7. Blood (1991) 77: 2612-17.
81. Hardy RR, Carmack CE, Shinton SA et al, Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med (1991) 173: 1213-25.
82. Li Y, Hayakawa K, Hardy RR, The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J Exp Med (1993) 178: 951-60.
83. Ryan DH, Nuccie BL, Ritterman I et al, Cytokine regulation of early human lymphopoiesis. J Immunol (1994) 152: 5248-9.
84. Era T, Ogawa M, Nishikawa S et al, Differentiation of growth signal requirement of B lymphocyte precursor is directed by expression of immunoglobulin. EMBO J (1991) 10: 337-42.
85. Henderson AJ, Narayanan R, Collins L, Dorshkind K, Status of kappa L chain gene rearrangements and c-kit and IL-7 receptor expression in stromal cell-dependent pre-B cells. J Immunol (1992) 149: 1973-9.
86. Joshi PC, Choi YS, Human interleukin 7 is a B cell growth factor for activated B cells. Eur J Immunol (1991) 21: 681-6.
87. Dittel BN, LeBien TW, The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. J Immunol (1995) 154: 58-67.
88. Stephan RP, Lill-Elghanian DA, Witte PL, Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors, J Immunol (1997) 158: 1598-609.
89. DiSanto JP, Muller W, Guy-Grand D et al, Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA (1995) 92: 377-81.
90. Cao X, Shores EW, Hu-Li J et al, Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity (1995) 2: 223-38.
91. Thomis DC, Burniak CB, Tivol E et al, Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science (1995) 270: 794-7.
92. Park SY, Saijo K, Takahashi T et al, Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity (1995) 3: 771-82.
93. Corcoran AE, Riddell A, Krooshoop D, Venkitaraman AR, Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature (1998) 391: 904-7.
94. Montgomery RA, Dallman MJ, Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol (1991) 147: 554-60.
95. Wiles MV, Ruiz P, Imhof BA, Interleukin-7 expression during mouse thymus development. Eur J Immunol (1992) 22: 1037-42.
96. Moore NC, Anderson G, Smith CA et al, Analysis of cytokine gene expression in subpopulations of freshly isolated thymocytes and thymic stromal cells using semiquantitative polymerase chain reaction. Eur J Immunol (1993) 23: 922-7.
97. Plum J, De Smedt M, Leclercq G, Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/-precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture. J Immunol (1993) 150: 2706-16.
98. Sudo T, Nishikawa S, Ohno N et al, Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci USA (1993) 90: 9125-9.
99. Okazaki H, Ito M, Sudo T et al, IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing alpha beta or gamma delta T-cell receptors in vitro: synergism with IL-2. J Immunol (1989) 143: 2917-22.
100. Everson MP, Eldridge JH, Koopman WJ, Synergism of interleukin 7 with the thymocyte growth factors interleukin 2, interleukin 6, and tumor necrosis factor alpha in the induction of thymocyte proliferation. Cell Immunol (1990) 127: 470-82.
101. Godfrey DI, Zlotnik A, Suda T, Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol (1992) 149: 2281-5.
102. Morrissey PJ, McKenna H, Widmer MB et al, Steel factor (c-kit ligand) stimulates the in vitro growth of immature CD3-/CD4-/CD8-thymocytes: synergy with IL-7. Cell Immunol (1994) 157: 118-31.
103. Suda T, Murray R, Guidos C, Zlotnik A, Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3-double-negative thymocytes. J Immunol (1990) 144: 3039-45.
104. Schorle H, Holtschke R, Hunig T et al, Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature (1991) 352: 621-4.
105. Kuhn R, Rajewsky K, Muller W, Generation and analysis of interleukin-4 deficient mice. Science (1991) 254: 707-80.
106. Maraskovsky E, Teepe M, Morrissey PJ et al, Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells. J Immunol (1996) 157: 5315-23.
107. Bhatia SK, Tygrett LT, Grabstein KH, Waldschmidt TJ, The effect of in vivo IL-7 deprivation on T cell maturation. J Exp Med (1995) 181: 1399-409.
108. Grabstein KH, Waldschmidt TJ, Finkelman FD et al, Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med (1993) 178: 257-64.
109. Rich BE, Leder P, Transgenic expression of interleukin 7 restores T cell populations in nude mice. J Exp Med (1995) 181: 1223-8.
110. Talmadge JE, Jackson JD, Kelsey L et al, T-cell reconstitution by molecular, phenotypic, and functional analysis in the thymus, bone marrow, spleen, and blood following split-dose polychemotherapy and therapeutic activity for metastatic breast cancer in mice. J Immunother (1993) 14: 258-68.
111. - murine thymocytes positively selected by class I molecules. J Exp Med (1994) 180: 653-61.
112. Boesteanu A, Silva ADD, Nakajima H et al, Distinct roles for signals relayed through the common cytokine receptor gamma chain and interleukin 7 receptor alpha chain in natural T cell development. J Exp Med (1997) 186: 331-6.
113. Maki K, Sunaga S, Komagata Y et al, Interleukin 7 receptor-deficient mice lack γδ T cells. Proc Natl Acad Sci USA (1996) 93: 7172-7.
114. He Y-W, Malek TR, Interleukin-7 receptor α is essential for the development of γδ+ T cells, but not natural killer cells. J Exp Med (1996) 184: 289-93.
115. Moore TA, von Freeden-Jeffry U, Murray R, Zlotnik A, Inhibition of γδ T cell development and early thymocyte maturation in IL-7-/-mice. J Immunol (1996) 157: 2366-73.
116. Heinrich DW, Ziegler HK, αβ and γδ T cells from Listeria monocytogenes (LM) immunized mice differ in their IL-7 receptor expression. In: Proceedings of the Experimental Biology Meeting, Atlanta, GA, 1995, A1062 (abst).
117. Leclercq G, De Smedt M, Plum J, Cytokine production and responsiveness of fetal T-cell receptor V gamma 3 thymocytes. Scand J Immunol (1992) 36: 833-41.
118. Leclercq G, De Smedt M, Plum J, Presence of CD8 alpha-CD8 beta-positive TcR gamma/delta thymocytes in the fetal murine thymus and their in vitro expansion with interleukin-7. Eur J Immunol (1992) 22: 2189-93.
119. Lynch F, Shevach EM, Activation requirements of newborn thymic gamma delta T cells. J Immunol (1992) 149: 2307-14.
120. He W, Kabelitz D, Differential effects of interleukin-7 and interleukin-2 on T-cell receptor gamma delta-expressing cells within CD4-CD8-postnatal human thymocytes. Int Arch Allergy Immunol (1993) 102: 321-6.
121. Tomana M, Ideyama S, Iwai K et al, Involvement of IL-7 in the development of gamma delta T cells in the thymus. Thymus (1993) 21: 141-57.
122. -) human thymocytes. J Immunol (1995) 154: 3726-31.
123. Maki K, Sunaga S, Ikuta K, The V-J recombination of T cell receptor-γ genes is blocked in interleukin-7 receptor-deficient mice. J Exp Med (1996) 184: 2423-7.
124. Candeias S, Peschon JJ, Muegge K, Durum SK, Defective T-cell receptor γ gene rearrangement in interleukin-7 receptor knockout mice. Immunol Lett (1997) 57: 9-14.
125. Appasamy PM, IL7-induced T cell receptor-gamma gene expression by pre-T cells in murine fetal liver cultures. J Immunol (1992) 149: 1649-56.
126. Appasamy PM, Kenniston TW Jr, Weng Y et al, Interleukin 7-induced expression of specific T cell receptor gamma variable region genes in murine fetal liver cultures. J Exp Med (1993) 178: 2201-6.
127. Appasamy PM, Weng Y, Kenniston TW Jr et al, Expression of diverse and functional TCRγ and Ig heavy chain transcripts in fetal liver cells cultured with IL-7. Mol Immunol (1995) 32: 805-17.
128. Soloff RS, Wang T-G, Dempsey D et al, Interleukin 7 induces TCR gene rearrangement in adult marrow-resident murine precursor T cells. Mol Immunol (1997) 34: 453-62.
129. Morrissey PJ, Goodwin RG, Nordan RP et al, Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med (1989) 169: 707-16.
130. Grabstein KH, Namen AE, Shanebeck K et al, Regulation of T cell proliferation by IL-7. J Immunol (1990) 144: 3015-20.
131. Armitage RJ, Namen AE, Sassenfeld HM, Grabstein KH, Regulation of human T cell proliferation by IL-7. J Immunol (1990) 144: 938-41.
132. Webb LM, Foxwell BM, Feldmann M, Interleukin-7 activates human naive CD4+ cells and primes for interleukin-4 production. Eur J Immunol (1997) 27: 633-40.
133. Hickman CJ, Crim JA, Mostowski HS, Siegel JP, Regulation of human cytotoxic T lymphocyte development by IL-7. J Immunol (1990) 145: 2415-20.
134. Bertagnolli M, Herrmann S, IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes. Multiple lymphokines required for proliferation and cytotoxicity. J Immunol (1990) 145: 1706-12.
135. Mehrotra PT, Grant AJ, Siegel JP, Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol (1995) 154: 5093-102.
136. Sica D, Rayman P, Stanley J et al, Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma. Int J Cancer (1993) 53: 941-7.
137. Ditonno P, Tso CL, Sakata T et al, Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytes. Urol Res (1992) 20: 205-10.
138. Lotze MT, Zeh HJ III, Elder EM et al, Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma. J Immunother (1992) 12: 212-17.
139. Lynch DH, Miller RE, Induction of murine lymphokine-activated killer cells by recombinant IL-7. J Immunol (1990) 145: 1983-90.
140. Alderson MR, Sassenfeld HM, Widmer MB, Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood. J Exp Med (1990) 172: 577-87.
141. Stotter H, Custer MC, Bolton ES et al, IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. J Immunol (1991) 146: 150-5.
142. Naume B, Espevik T, Effects of IL-7 and IL-2 on highly enriched CD56+ natural killer cells. A comparative study. J Immunol (1991) 147: 2208-14.
143. Naume B, Gately M, Espevik T, A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol (1992) 148: 2429-36.
144. Ting C-C, Wang J, Yang Y, Interleukin-2 and interleukin-7 augment the cytolytic activity and expand the antitumor killing spectrum of α CDS-induced activated killer cells: potential use in the immunotherapy of non-immunogenic tumors. Cancer Immunol Immunother (1996) 43: 283-92.
145. Maraskovsky E, O'Reilly LA, Teepe M et al, Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in rag-1-/-mice. Cell (1997) 89: 1011-19.
146. Akashi K, Kondo M, von Freeden-Jeffry U et al, Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell (1997) 89: 1033-1041.
147. Lotzova E, Definition and functions of natural killer cells. Nat Immun (1993) 12: 169-76.
148. Pollack SB, Tsuji J, Effects of rIL-7 on murine bone marrow NK precursor cells. Cell Immunol (1993) 151: 1-11.
149. Naume B, Johnsen AC, Espevik T, Sundan A, Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur J Immunol (1993) 23: 1831-8.
150. Robertson MJ, Manley TJ, Donahue C et al, Costimulatory signals are required for optimal proliferation of human natural killer cells. J Immunol (1993) 150: 1705-14.
151. Damia G, Komschlies KL, Faltynek CR et al, Administration of recombinant human interleukin-7 alters the frequency and number of myeloid progenitor cells in the bone marrow and spleen of mice. Blood (1992) 79: 1121-9.
152. Faltynek CR, Wang S, Miller D et al, Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage. J Immunol (1992) 149: 1276-82.
153. Grzegorzewski K, Komschlies KL, Mon M et al, Administration of recombinant human interleukin-7 to mice induces the exportation of myeloid progenitor cells from the bone marrow to peripheral sites. Blood ( 1994) 83: 377-85.
154. Jacobsen FW, Veiby OP, Skjonsberg C, Jacobsen SE, Novel role of interleukin 7 in myelopoiesis: stimulation of primitive murine hematopoietic progenitor cells. J Exp Med (1993) 178: 1777-82.
155. Fahlman C, Blomhoff HK, Veiby OP et al, Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro. Blood (1994) 84: 1450-6.
156. - myeloid progenitors in vitro. J Immunol (1994) 153: 270-6.
157. Jacobsen FW, Rusten LS, Jacobsen SE, Direct synergistic effects of interleukin-7 on in vitro myelopoiesis of human CD34+ bone marrow progenitors. Blood (1994) 84: 775-9.
158. Alderson MR, Tough TW, Ziegler SF, Grabstein KH, Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J Exp Med (1991) 173: 923-30.
159. Ziegler SF, Tough TW, Franklin TL et al. Induction of macrophage inflammatory protein-1 beta gene expression in human monocytes by lipopolysaccharide and IL-7. J Immunol (1991) 147: 2234-9.
160. Standiford TJ, Stricter RM, Allen RM et al, IL-7 up-regulates the expression of IL-8 from resting and stimulated human blood monocytes. J Immunol (1992) 149: 2035-9.
161. Gessner A, Vieth M, Will A et al, Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages. Infect Immun (1993) 61: 4008-12.
162. Dalloul A, Laroche L, Bagot M et al, Interleukin-7 is a growth factor for Sézary lymphoma cells. J Clin Invest (1992) 90: 1054-60.
163. Watanabe M, Ueno Y, Yajima T et al, Interleukin-7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest (1995) 95: 2945-53.
164. Bilenker M, Roberts AI, Brolin RE, Ebert EC, Interleukin-7 activates intestinal lymphocytes. Dig Dis Sci (1995) 40: 1744-9.
165. Maeurer MJ, Walter W, Martin D et al, Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes. Scand J Immunol (1997) 45: 182-92.
166. Watanabe M, Ueno Y, Yajima T et al, Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonie mucosa. J Exp Med (1988) 187: 389-402.
167. Fujihashi K, McGhee JR, Yamamoto M et al, An interleukin-7 internet for intestinal intraepithelial T cell development: knockout of ligand or receptor reveal differences in the immunodeficient state. Eur J Immunol (1997) 27: 2133-8.
168. Bui T, Faltynek C, Ho RJ, Differential disposition of soluble and liposome-formulated human recombinant interleukin-7: effects on blood lymphocyte population in guinea pigs. Pharm Res (1994) 11: 633-41.
169. Lynch DH, Namen AE, Miller RE, In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes. Eur J Immunol (1991) 21: 2977-85.
170. Lynch DH, Miller RE, Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J Exp Med (1994) 179: 31-42.
171. Jicha DL, Mule JJ, Rosenberg SA, Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. J Exp Med (1991) 174: 1511-15.
172. Murphy WJ, Back TC, Conlon KC et al, Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts. J Clin Invest (1993) 92: 1918-24.
173. Wu B, Shen RN, Wang WX et al, Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells. Stem Cells (1993) 11: 412-21.
174. Cayeux S, Beck C, Aicher A et al, Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. Eur J Immunol (1995) 25: 2325-31.
175. Arthur JF, Butterfield LH, Roth MD et al, A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther (1997) 4: 17-25.
176. Schmidt-Wolf IGH, Huhn D, Neubauer A, Wittig B, Interleukin-7 gene transfer in patients with metastatic colon carcinoma, renal cell carcinoma, melanoma, or with lymphoma. Hum Gene Ther (1994) 5: 1161-8.
177. Bolotin E, Smogorzewska M, Smith S et al, Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin 7. Blood (1996) 88: 1887-94.
178. Grzegorzewski KJ, Komschlies KL, Franco JL et al, Quantitative and cell-cycle differences in progenitor cells mobilized by recombinant human interleukin-7 and recombinant human granulocyte colony-stimulating factor. Blood (1996) 88: 4139-48.
179. Lu L, Zhou Z, Wu B et al, Influence of recombinant human interleukin (IL)-7 on disease progression in mice infected with Friend virus complex. Int J Cancer (1992) 52: 261-5.
180. Wiryana P, Bui T, Faltynek CR, Ho RJY, Augmentation of cell-mediated immunotherapy against herpes simplex virus by interleukins: comparison of in vivo effects of IL-2 and IL-7 on adoptively transferred cells. Vaccine (1997) 15: 561-3.
181. Gessner A, Will A, Vieth M et al, Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis. Immunology (1995) 84: 416-22.
182. Bui T, Dykers T, Hu SL et al, Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein. J Acq Immune Defic Syndr (1994) 7: 799-806.
183. Kasper LH, Matsuura T, Khan IA, IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii. J Immunol (1995) 155: 4798-804.
184. Witte PL, Frantsve LM, Hergott M, Rahbe SM, Cytokine production and heterogeneity of primary stromal cells that support B lymphopoiesis. Eur J Immunol (1993) 23: 1809-17.
185. Sakata T, Iwagami S, Tsuruta Y et al, Constitutive expression of interleukin-7 mRNA and production of IL-7 by a cloned murine thymic stromal cell line. J Leukoc Biol (1990) 48: 205-12.
186. Gutierrez JC, Palacios R, Heterogeneity of thymic epithelial cells in promoting T-lymphocyte differentiation in vivo. Proc Natl Acad Sci USA (1991) 88: 642-6.
187. Kroncke R, Loppnow H, Flad HD, Gerdes J, Human follicular dendritic cells and vascular cells produce interleukin-7: a potential role for interleukin-7 in the germinal center reaction. Eur J Immunol (1996) 26: 2541-4.
188. Michaelson MD, Mehler MF, Xu H et al, Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. Dev Biol (1996) 179: 251-63.
189. Asseman C, Pancre V, Quatennens B, Auriault C, Schistosoma mansoni-infected mice show augmented hepatic fibrosis and selective inhibition of liver cytokine production after treatment with anti-NK1.1 antibodies. Immunol Lett (1996) 54: 11-20.
190. Soslau G, Morgan DA, Jaffe JS et al, Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function. Cytokine (1997) 9: 405-11.
191. Frishman J, Long B, Knospe W et al, Genes for interleukin 7 are transcribed in leukemic cell subsets of individuals with chronic lymphocytic leukemia. J Exp Med (1993) 177: 955-64.
192. Plate JM, Knospe WH, Harris JE, Gregory SA, Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias. Hum Immunol (1993) 36: 249-58.
193. Benjamin D, Sharma V, Knobloch TJ et al, Human B cell lines constitutively secrete IL-7 and express IL7 receptors. J Immunol (1994) 152: 4749-57.
194. Kaashoek JGJ, Mout R, Falkenburg JHF et al, Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. Lymphokine Cytokine Res (1991) 10: 231-5.
195. Mattei S, Colombo MP, Melani C et al, Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer (1994) 56: 853-7.
196. Melhem MF, Meisler AI, Saito R et al, Cytokines in inflammatory malignant fibrous histiocytoma presenting with leukemoid reaction. Blood (1993) 82: 2038-44.
197. Aoki T, Tashiro K, Miyatake S et al. Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc Natl Acad Sci USA (1992) 89: 3850-4.
198. Allione A, Consalvo M, Nanni P et al, Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants. Cancer Res (1994) 54: 6022-6.
199. Hock H, Dorsch M, Diamantstein T, Blankenstein T, Interleukin 7 induces CD4+ T cell-dependent tumor rejection. J Exp Med (1991) 174: 1291-8.
200. Hock H, Dorsch M, Kunzendorf U et al, Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci USA (1993) 90: 2774-8.
201. McBride WH, Thacker JD, Comora S et al. Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res (1992) 52: 3931-7.
202. Miller AR, McBride WH, Dubinett SM et al, Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2. Blood (1993) 82: 3686-94.